Meridian unit Magellan in hot water with FDA over lead test results
Meridian Bioscience unit Magellan Diagnostics is not out of the woods yet related to potential inaccurate results from a blood test for lead performed on its equipment. In a statement released today, the agency said that an on-site inspection of the company's North Billerica, MA facility identified nine observations that could potentially be violations of federal law.
from Biotech News
0 Comments